QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

EVH

QT77Evolent Health, Inc.
NYSE·Healthcare·Medical - Healthcare Information Services·USA
Latest market price
4.49
-0.18-3.85%
OverviewShort InterestFilings
EVHQT77Evolent Health, Inc.·NYSE
OverviewShort InterestFilings
4.49-3.85%
TA
Loading chart...
Screen all →
GEHC+0.72%$61.59VEEV-1.00%$153.30BTSG+2.82%$66.25TEM+4.20%$50.84HQY-1.30%$85.21HNGE+3.55%$69.42TXG+8.19%$34.76DOCS+0.05%$20.46
Snapshot
Index-P/E-EPS (ttm)
-4.68
Insider Own5.55%
Shs Outstand112.48M
Perf Week-1.97%
Market Cap525.29MForward P/E12.28EPS next Y0.37Insider Trans0.00%Shs Float-Perf Month15.42%
Enterprise Value1.34BPEG0.01EPS next Q-0.01Inst Own-Short Float-Perf Quarter63.87%
Income-499074783.00P/S0.28EPS this Y103.87%Inst Trans-Short Ratio-Perf Half Y10.32%
Sales1.89BP/B1.32EPS next Y101.88%ROA-26.43%Short Interest-Perf YTD12.25%
Book/sh3.52P/C15.70EPS next 5Y46.30%ROE-77.89%52W High12.07 -62.80%Perf Year-47.11%
Cash/sh1.48P/FCF376.55EPS past 3/5Y-ROIC-1.08%52W Low2.10 113.81%Perf 3Y-
Dividend Est.-EV/EBITDA-4.28Sales past 3/5Y11.54% 15.19%Gross Margin14.13%Volatility4.40% 4.62%Perf 5Y-
Dividend TTM-EV/Sales0.71EPS Y/Y TTM101.23%Oper. Margin-0.86%ATR (14)0.32Perf 10Y-
Dividend Ex-Date-Quick Ratio1.32Sales Y/Y TTM-26.07%Profit Margin-26.29%RSI (14)56.54Recom2.00
Dividend Gr. 3/5Y-Current Ratio1.32EPS Q/Q-133.33%SMA205.04%Beta0.91Target Price6.38
Payout-1.32%Debt/Eq2.49Sales Q/Q2.48%SMA5018.29%Rel Volume1.08Prev Close4.67
Employees4,500LT Debt/Eq2.35EarningsAug 06SMA200-3.59%Avg Volume2.63MPrice4.49
IPO DateJun 05, 2015Option/ShortYes / YesEPS/Sales Surpr.60.00% -7.12%Net Debt/EBITDA-2.61Volume2,840,282Change-3.85%
Analyst Ratings
DateActionAnalystRatingTarget
May-12-26ReiteratedCanaccord GenuityBuy$44 → $6.00
Feb-25-26ReiteratedTruist Financial$10 → $6.00
Feb-25-26ReiteratedBMO Capital$3.50
Feb-25-26DowngradeKeybancOverweight → Sector Weight
Feb-02-26ReiteratedBTIGBuy$50 → $10
Dec-02-25ReiteratedPiper SandlerOverweight$51 → $6.00
Jan-16-25ReiteratedUBSBuy$14
Jan-15-25ReiteratedTruist Financial$33 → $20
Jan-14-25ReiteratedRBC CapitalOutperform$42 → $17
Jan-10-25ReiteratedJMP SecuritiesMarket Outperform$18
Latest News
Jun-12-26
Jun-12-2610:11AM
Truist Securities Maintains Buy on Evolent Health, Raises Price Target to $7Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,8891,8762,555
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A1,6221,5922,187
Gross Profit267284367
Selling, General and Administrative Excl. Other283288263
Research and Development000
Other Operating Expense00145
Operating Income-16-4-40
Interest Expense645725
Unusual Expense
———
Non-Operating Income (Expense)417473-2
Net Income Before Taxes-498-535-63
Income Taxes-10-1
Consolidated Net Income-497-535-62
Net Income From Continuing Operations-497-535-62
Net Income-497-535-62
EPS (Recurring)-4.68-5.07-0.81
EPS (Basic, Before Extraordinaries)-4.68-5.07-0.81
EPS (Diluted)-4.68-5.07-0.81
EBITDA-315-36185
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio0.270.24—
Gross Margin14.1315.1414.36
Operating Margin-0.85-0.21-1.57
Net Margin-26.31-28.52-2.43
Shares Outstanding112114115
Market Capitalization503456—
Operating Lease Expense
———
Insider Trading Volume
$4.84$4.40$3.96$3.52$3.08● Close Price0.00K9.55K19.10K28.65K38.20KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Springstubb Brendan BDirectorNov 18 '25Buy3.8210,00038,19958,821Nov 19 12:00 AM
Springstubb Brendan BDirectorMar 07 '25Buy9.2715,000139,05026,842Mar 10 12:00 AM
Jelinek Richard MDirectorMar 07 '25Buy9.1330,000273,75015,000Mar 10 12:00 AM
KECK KIMDirectorMar 07 '25Buy9.4410,54099,49839,522Mar 10 12:00 AM
Glass Russell MonroeDirectorMar 06 '25Buy9.275,40050,05814,272Mar 10 12:00 AM
Barbarosh Craig A.DirectorMar 06 '25Buy8.812,00017,62031,956Mar 10 12:00 AM
Holder DianeDirectorMar 06 '25Buy9.332,73525,51870,584Mar 10 12:00 AM
McCarthy Daniel JosephPRESIDENTMar 06 '25Buy9.0111,04099,470389,004Mar 10 12:00 AM
GRUA PETER JDirectorMar 06 '25Buy9.0111,04099,47018,749Mar 10 12:00 AM
Blackley SethChief Executive OfficerMar 06 '25Buy9.0155,225497,577762,217Mar 10 12:00 AM
Springstubb Brendan BDirectorMar 04 '25Buy8.755,00043,75011,842Mar 05 12:00 AM
McCarthy Daniel JosephPRESIDENTAug 23 '24Sale32.3810,469339,008188,340Aug 26 12:00 AM
Blackley SethChief Executive OfficerAug 22 '24Option Exercise8.27340,6462,818,434599,828Aug 26 12:00 AM
McCarthy Daniel JosephPRESIDENTAug 22 '24Option Exercise24.759,100225,226222,502Aug 26 12:00 AM
McCarthy Daniel JosephPRESIDENTAug 22 '24Sale30.8923,693731,790198,809Aug 26 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR